Clostridium Infections: all 251 studies

Page 3 of 3. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)CompletedNCT02784002Phase 2
• Fecal Microbiota Transplantation for Relapsing Clostridium Difficile InfectionCompletedNCT02743234Phase 3
• Fecal Microbiota Therapy for Recurrent Clostridium Difficile InfectionStatus unknownNCT02686645Phase 2/3
• MicroTrans - A Multicenter Registry of Fecal Microbiota TransplantationStatus unknownNCT02681068
• FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota AssessmentStatus unknownNCT02570477Not applicable
• Gut Microbiota Changes After Fecal Microbiota TransplantationStatus unknownNCT02557685Phase 2
• Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile InfectionWithdrawnNCT02464306Phase 4
• Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?CompletedNCT02461901
• Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)CompletedNCT02437591Phase 4
• Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)Approved for marketingNCT02437500
• Freeze-dried, Capsulized FMT for RCDIStatus unknownNCT02399618Phase 1
• Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide StudyCompletedNCT02327520
• Fecal Microbiota Transplant for Recurrent Clostridium Difficile InfectionCompletedNCT02326636
• IMT for Primary Clostridium Difficile InfectionTerminatedNCT02301000Phase 2/3
• Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICUCompletedNCT02290327Phase 3
• Vancomycin Prophylaxis in Recurrent Clostridium Difficile InfectionStatus unknownNCT02237859Phase 4
• Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These PatientsCompletedNCT02214771
• Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile InfectionCompletedNCT02148601Phase 2
• Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.CompletedNCT02106338Phase 1
• A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)CompletedNCT02092935Phase 2
• Novel Biomarkers to Predict Outcome in Clostridium Difficile InfectionCompletedNCT02086916
• Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile InfectionCompletedNCT02053181Phase 1
• Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated DiarrheaTerminatedNCT01972932Phase 4
• Transplantation of Fecal Microbiota for Clostridium Difficile InfectionStatus unknownNCT01958463Phase 3
• Predictive Value of the Immune Response of the Host in Clostridium Difficile InfectionsCompletedNCT01946750Not applicable
• Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile ColitisStatus unknownNCT01942447Not applicable
• Pathogenic Mechanisms in C Diff Infection and ColitisCompletedNCT01930032
• Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated InoculumCompletedNCT01914731Phase 1
• Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in JapanCompletedNCT01896830Phase 1/2
• Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)WithdrawnNCT01842347Not applicable
• The Impact of Proton Pump Inhibitors on the Fecal MicrobiomeCompletedNCT01822977Phase 1
• Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen InoculumCompletedNCT01704937Phase 1
• Rifaximin for Preventing Relapse of Clostridium Associated DiarrhoeaCompletedNCT01670149Phase 4
• Hospital Wide Roll-Out of Antimicrobial StewardshipCompletedNCT01587937Not applicable
• Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific RegionCompletedNCT01560832
• Fidaxomicin to Prevent Clostridium Difficile ColonizationWithdrawnNCT01552668Phase 4
• Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDICompletedNCT01398969Phase 2
• Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile InfectionTerminatedNCT01372943Not applicable
• An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84CompletedNCT01296386Phase 1
• Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized ChildrenCompletedNCT01295918Phase 3
• Vaginal and Rectal Clostridial Carriage Among Women of Reproductive Age in the United StatesCompletedNCT01283828
• Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in AdultsCompletedNCT01230957Phase 2
• Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral VancomycinTerminatedNCT01226992Phase 2/3
• Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)CompletedNCT01222702Phase 2
• BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile InfectionSuspendedNCT01202630Phase 3
• Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile InfectionsWithdrawnNCT01077245Phase 2
• Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile InfectionCompletedNCT00772343Phase 2
• Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC GenotypesCompletedNCT00446355
• Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated DiseaseTerminatedNCT00384527Phase 3
• Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired InfectionsCompletedNCT00130221Phase 1
• Study of Human Botulism Immunoglobulin in Infants With BotulismCompletedNCT00004401Not applicable

← Clostridium Infections overview